Magnetic resonance imaging characteristics of LGI1-antibody and CASPR2-antibody encephalitis

Magnetic resonance imaging characteristics of LGI1-antibody and CASPR2-antibody encephalitis

<p><b>Importance</b> Rapid and accurate diagnosis of autoimmune encephalitis encourages prompt initiation of immunotherapy toward improved patient outcomes. However, clinical features alone may not sufficiently narrow the differential diagnosis, and awaiting autoantibody results c...

Full description

Bibliographic Details
Main Authors:	Kelly, MJ, Grant, E, Murchison, AG, Binks, S, Ramanathan, S, Michael, S, Handel, AE, Handunnetthi, L, Uy, CE, Soltys, JN, Dubey, D, Day, GS, Lopez-Chiriboga, AS, Flanagan, EP, Sheerin, F, Irani, SR
Format:	Journal article
Language:	English
Published:	American Medical Association 2024

Similar Items

The immunogenetics of LGI1- and CASPR2-antibody encephalitis: towards aetiology
by: Binks, S
Published: (2022)

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
by: Binks, S, et al.
Published: (2017)

Distinct HLA associations of LGI1 and CASPR2-antibody diseases
by: Binks, S, et al.
Published: (2018)

The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis
by: Goevert, F, et al.
Published: (2019)

Hippocampal epileptogenesis in LGI1, CASPR2 and GABABR antibodies: preliminary findings
by: Romoli, M, et al.
Published: (2020)

007 Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
by: Russell C Dale, et al.
Published: (2021-08-01)

Phenotypic Spectrum of CASPR2 and LGI1 Antibodies Associated Neurological Disorders in Children
by: Yan Jiang, et al.
Published: (2022-04-01)

Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
by: Dubey, D, et al.
Published: (2019)

Caspr2 antibodies in patients with thymomas.
by: Vincent, A, et al.
Published: (2010)

CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
by: Michael, S, et al.
Published: (2019)

Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology
by: Binks, S, et al.
Published: (2020)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
by: Jang, Y, et al.
Published: (2018)

Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
by: Dubey, D, et al.
Published: (2019)

Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
by: Lang, B, et al.
Published: (2017)

Intrathecal B cell activation in LGI1-antibody encephalitis
by: Lehmann-Horn, K, et al.
Published: (2020)

Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis.
by: Tofaris, G, et al.
Published: (2012)

Contactin-2 associated protein (CASPR2) autoimmune neurological conditions: Detailed clinical phenotype and antibody quantification
by: Varley, J, et al.
Published: (2017)

Investigating B cell biology in CASPR2-antibody encephalitis
by: Sun, B
Published: (2022)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
by: Yoonhyuk Jang, et al.
Published: (2018-09-01)

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
by: Michael, S, et al.
Published: (2020)

LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures
by: Aurangzeb, S, et al.
Published: (2017)

Clinical features of limbic encephalitis with LGI1 antibody
by: Wang ML, et al.
Published: (2017-06-01)

Flortaucipir (tau) PET in LGI1 antibody encephalitis
by: Gregory S. Day, et al.
Published: (2021-02-01)

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
by: Irani, SR, et al.
Published: (2011)

Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis
by: Binks, SNM, et al.
Published: (2024)

Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis
by: Susann Ludewig, et al.
Published: (2023-01-01)

Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies
by: Jianping Qiao, et al.
Published: (2020-04-01)

Anti-CASPR2 antibody-associated autoimmune encephalitis： a case report
by: Xing Xin, et al.
Published: (2023-02-01)

Clinical Features and Outcomes in Pediatric Autoimmune Encephalitis Associated With CASPR2 Antibody
by: Chengbing Tan, et al.
Published: (2021-10-01)

Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
by: Li-li Cui, et al.
Published: (2021-12-01)

Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
by: Binks, S, et al.
Published: (2020)

Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies.
by: Sen, A, et al.
Published: (2014)

LGI1-Antibody associated autoimmune encephalitis complicated by primary polydipsia
by: Arjimand Yaqoob, et al.
Published: (2022-01-01)

Hemichorea Associated with CASPR2 Antibody
by: Iryna Vynogradova, et al.
Published: (2014-05-01)

Clinical diagnosis of LGI1 antibody encephalitis in an 83-year-old woman
by: Attwood, JE, et al.
Published: (2021)

Autoimmune encephalitis with coexistent LGI1 and GABABR1 antibodies: case report
by: Yi Xie, et al.
Published: (2021-11-01)

Case report: Autoimmune encephalitis associated with anti-CASPR2 antibody mimicking cerebral infarction
by: Ziqi Chen, et al.
Published: (2023-01-01)

Evaluation of LGI1-antibody Encephalitis, a Rare Cause of Limbic Encephalitis, from Diagnosis to Treatment
by: Halil İbrahim Uslusoy, et al.
Published: (2022-06-01)

Reply to: Hemichorea Associated with CASPR2 Antibody
by: Ritesh A. Ramdhani, et al.
Published: (2014-05-01)

CSF Findings in Chinese Patients with NMDAR, LGI1 and GABABR Antibody-Associated Encephalitis
by: Qiao S, et al.
Published: (2024-03-01)